Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, vTv Therapeutics Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 63.15%, while the net margin is 65.51%. These profitability ratios, combined with a Return on Equity (ROE) of 4.60%, provide a clear picture of how effectively VTVT converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, VTVT competes directly with industry leaders such as GNLX and ATLN. With a market capitalization of $129.98M, it holds a significant position in the sector. When comparing efficiency, VTVT's gross margin of 100.00% stands against GNLX's N/A and ATLN's 8.12%. Such benchmarking helps identify whether vTv Therapeutics Inc is trading at a premium or discount relative to its financial performance.
